Literature DB >> 4347596

Prevention of cell-to-cell spread of herpes simplex virus by leukocytes.

D L Lodmell, A Niwa, K Hayashi, A L Notkins.   

Abstract

Antibody to herpes simplex virus (HSV) plus complement destroyed HSV-infected cells but did not stop the spread of the infection. Studies on the relationship between the time of appearance of viral antigens on the cell surface, immunological destruction of the cells by antiviral antibody and complement, and transfer of the virus to adjacent cells showed that the virus spread from infected to uninfected cells before the infected cells were susceptible to immunological destruction. Incubation of infected monolayers with leukocytes, however, stopped the spread of the virus by nonspecifically damaging both infected and uninfected cells and by presumably breaking intercellular bridges. When leukocytes were removed from infected monolayers, viral plaques developed. If, however, antiviral antibody and complement were added to monolayers before the leukocytes were removed, the development of plaques was prevented. These findings suggest that both antibody and leukocytes are needed to cure HSV infections.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4347596      PMCID: PMC2139378          DOI: 10.1084/jem.137.3.706

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

1.  Mechanism of immunologically specific killing of tumour cells by macrophages.

Authors:  R Evans; P Alexander
Journal:  Nature       Date:  1972-03-24       Impact factor: 49.962

2.  Inflammation and viral infection: chemotactic activity resulting from the interaction of antiviral antibody and complement with cells infected with herpes simplex virus.

Authors:  R Snyderman; C Wohlenberg; A L Notkins
Journal:  J Infect Dis       Date:  1972-08       Impact factor: 5.226

3.  Infectious virus-antibody complexes: interaction with anti-immunoglobulins, complement, and rheumatoid factor.

Authors:  A L Notkins
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

4.  Selective effects of anti-macrophage serum, silica and anti-lymphocyte serum on pathogenesis of herpes virus infection of young adult mice.

Authors:  B Zisman; M S Hirsch; A C Allison
Journal:  J Immunol       Date:  1970-05       Impact factor: 5.422

5.  Macrophages and age-dependent resistance to Herpes simplex virus in mice.

Authors:  M S Hirsch; B Zisman; A C Allison
Journal:  J Immunol       Date:  1970-05       Impact factor: 5.422

Review 6.  Cytotoxic effects of lymphoid cells in vitro.

Authors:  P Perlmann; G Holm
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

7.  An in vitro measure of cellular immunity to fibroma virus.

Authors:  W A Tompkins; C Adams; W E Rawls
Journal:  J Immunol       Date:  1970-02       Impact factor: 5.422

Review 8.  N.A.S. symposium: new evidence as the basis for increased efforts in cancer research.

Authors:  G J Todaro; R J Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  1972-04       Impact factor: 11.205

9.  Iodine-125-labeled antibody to viral antigens: binding to the surface of virus-infected cells.

Authors:  K Hayashi; J Rosenthal; A L Notkins
Journal:  Science       Date:  1972-05-05       Impact factor: 47.728

10.  LEUKOCYTES AND INTERFERON IN THE HOST RESPONSE TO VIRAL INFECTIONS. I. MOUSE LEUKOCYTES AND LEUKOCYTE-PRODUCED INTERFERON IN VACCINIA VIRUS INFECTION IN VITRO.

Authors:  L A GLASGOW
Journal:  J Exp Med       Date:  1965-06-01       Impact factor: 14.307

View more
  40 in total

1.  Immune interferon production by lymphoid cells: role in the inhibition of herpesviruses.

Authors:  L A Babiuk; B T Rouse
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

2.  In vitro acquisition of resistance against herpes simplex virus by permissive murine macrophages.

Authors:  K K Sethi; H Brandis
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

3.  Cell-mediated immunity to varicella-zoster virus measured by virus inactivation: mechanism and blocking of the reaction by specific antibody.

Authors:  A A Gershon; S P Steinberg
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

4.  Defense mechanisms against infectious bovine rhinotracheitis virus: inhibition of virus infection by murine macrophages.

Authors:  B T Rouse; L A Babiuk
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

5.  Cell-mediated immunity to Herpes simplex in humans: lymphocyte cytotoxicity measured by 51-Cr release from infected cells.

Authors:  A S Russell; J S Percy; T Kovithavongs
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

6.  Effect of immunosuppression on the genetic resistance of A2G mice to neurovirulent influenza virus.

Authors:  R A Fiske; P A Klein
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

7.  Peripheral infection in culture of rat sensory neurons by herpes simplex virus.

Authors:  R J Ziegler; R E Herman
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

8.  Characterization of a type-common human recombinant monoclonal antibody to herpes simplex virus with high therapeutic potential.

Authors:  A De Logu; R A Williamson; R Rozenshteyn; F Ramiro-Ibañez; C D Simpson; D R Burton; P P Sanna
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

9.  Effect of treatment with BCG on the course of visceral leishmaniasis in BALB/c mice.

Authors:  L L Smrkovski; C L Larson
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

10.  Cell cytotoxicity due to specific influenza antibody production in vitro after recent influenza antigen stimulation.

Authors:  S B Greenberg; H R Six; S Drake; R B Couch
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.